The effects of combined therapy of rheumatoid arthritis on the acute phase reactants.
The paper presents the results of studies of acute phase reactants in the 60 treated patients with rheumatoid arthritis. Patients were divided into two groups, depending on the applied treatment: group I (n = 30) was treated with methotrexate, sulfasalazine and hydroxychloroquine, and group II (n = 30) with methotrexate. The results of our study shows that there is a statistically significant reduction in the value of acute phase reactants and clinical parameters after treatment in both investigated groups of patients, and also a significant statistical difference between the first and second group of treated patients.
Rexhepi
Sylejman
S
Faculty of Medicine, University of Pristina, Rr. "Bulevardi i dëshmorëve" p.n., 10000 Pristina, Kosovo.
Rexhepi
Mjellma
M
Sahatçiu-Meka
Vjollca
V
Pllana
Ejup
E
Dragusha
Gani
G
Gashi
Masar
M
Rexhepi
Blerta
B
D000209:Acute-Phase Proteins / Q000032:analysis*; D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000032:analysis; D004359:Drug Therapy, Combination; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D055815:Young Adult
D000209:Acute-Phase Proteins; D018501:Antirheumatic Agents; D005340:Fibrinogen; D002097:C-Reactive Protein